Suchergebnisse - "Dong, Jianbo"

PubPharm (11)

1

ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2023

von DONG JIANBO | HUANG CHAO BAI | LIU YUE

2

ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2023

von DONG JIANBO | HUANG CHAO BAI | LIU YUE

3

Targeting SARS-CoV-2 Viral-immune Interaction for COVID-19 Therapy

enthalten in: Europäisches Patentamt | 2022

von WANG JUN | LU QIAO | LIU JIA | +3

4

Targeting SARS-CoV-2 Viral-immune Interaction for COVID-19 Therapy

enthalten in: Europäisches Patentamt | 2022

von WANG JUN | LU QIAO | LIU JIA | +3

5

First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants

enthalten in: Scientific reports | 2022

von Titong, A. | Gallolu Kankanamalage, S. | Dong, J. | +7

6

ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2021

von DONG JIANBO | HUANG CHAO BAI | LIU YUE

7

ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2021

von DONG JIANBO | HUANG CHAO BAI | LIU YUE

8

SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2

enthalten in: Immunity | 2021

von Lu, Q. | Liu, J. | Zhao, S. | +47

9

Author Correction : Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

enthalten in: Scientific reports | 2021

von Dong, J. | Huang, B. | Wang, B. | +6

ErratumFor: Sci Rep. 2020 Oct 20;10(1):17806. - PMID 33082473

10

Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity

enthalten in: Emerging microbes & infections | 2020

von Dong, J. | Huang, B. | Jia, Z. | +4